The present invention is directed generally to tissue sample processing systems and in particular to systems and methods of dispensing reagents.
Tissue processors can be operated with varying levels of automation to process human or animal tissue specimens for histology or pathology uses. Various types of chemical reagents can be used at various stages of tissue processing and various systems have been developed for delivering reagents to microscope slides containing specimens. Examples of known reagent delivery systems include small quantity release dispensers, technicians manually pouring reagents into reagent vats, and bulk containers connected with a specimen processor via tubing.
There are various disadvantages of known systems. For example, a technician manually pouring reagents into, or draining, reagent vats suffers the disadvantages of being time consuming and requiring pouring accuracy which decreases the overall efficiency of the tissue processing system. Another disadvantage is that manually pouring and draining reagents can be sloppy, requiring clean-up of spills and consequential instrument down-time. A further disadvantage is that selecting the correct reagent requires operator attention and accuracy and there is an increased possibility of reagent application errors, which decreases test accuracy and operational efficiency.
In the previously known automated systems, there are also disadvantages. In those systems, reagents are selected and administered to slides during processing, frequently via gravity promoted dispensing from above. Such delivery systems require specialized equipment for reagent delivery such as specialized reagent dispensers, drivers or automated pipetting systems. Such systems suffer various drawbacks such as the amount of effort required to set up and dispense the reagents, the possibilities of evaporation during processing or contamination and difficulties in handling minute quantities of large numbers of reagents.
The present invention alleviates to a great extent the disadvantages of the known automated slide staining systems. The invention reduces errors and increases efficiency in tissue processing by providing a central controller that may simultaneously operate multiple stainers in a scheduled manner. The central controller initiates tissue processing either automatically, for example, on a scheduled basis, or manually upon receiving a start event condition. The stainers undergo an inventory procedure that determines the number and types of tissue samples provided on slides that have been placed on trays in the stainers. This procedure may include scanning a bar code or otherwise obtaining patient, tissue, reagent, and/or other types of information from the slides and/or trays provided in the stainer.
The stainer transmits all or a portion of this information to the central controller. Preferably, the central controller at least receives primary reagent information regarding the tissue samples. Based on the primary reagent information, the central controller determines a staining protocol to be applied to the tissue samples. The staining protocols are communicated to and stored by the stainer. The stainer may then operate independently of the central controller.
The central controller enables a user to obtain a status regarding one or more tissue processes, generate reports, modify reagent cartridge information, select programs to run, and initiate other functions. The central controller may also enable the user to manually initiate tissue processing for one or more of the stainers.
These and other features and advantages of the present invention will be appreciated from review of the following detailed description of the invention, along with the accompanying figures in which like reference numerals refer to like parts throughout.
In the following paragraphs, the present invention will be described in detail by way of example with reference to the figures. Throughout this description, the preferred embodiment and examples shown should be considered as exemplars, rather than as limitations on the present invention. As used herein, the “present invention” refers to any one of the embodiments of the invention described herein, and any equivalents. Furthermore, reference to various feature(s) of the “present invention” throughout this document does not mean that all claimed embodiments or methods must include the referenced feature(s).
Control computer 102 may also communicate with one or more local databases 110 so that data may be transferred to or from local databases 110. For example, local database 110 may store a plurality of staining protocols that are designed to be performed by stainers 104. The staining protocols implemented by stainers 104 may be chosen based on information obtained from identifiers (e.g., barcodes, radio frequency identification devices (RFID), etc.) associated with slides and/or trays used in the stainers, as further described below. Control computer 102 may process identification data received from stainers 104 and retrieve staining protocols from local database 110 and transmit the staining protocols to stainers 104. Furthermore, control computer 102 may use local databases 110 for storage of information received from stainers 104, such as reports and/or status information.
Control computer 102 may also communicate with one or more remote databases 112 and/or a server 114. Control computer 102 may communicate with remote database 112 directly or through server 114, which may be a laboratory information system (LIS). Control computer 102 may communicate with server 114 via a network 116. As noted above, server 114 may communicate with remote database 112. Server 114 and remote database 112 maybe used to provide staining protocols to be used by stainers 104 in a similar fashion as local database 110 or to supplement the protocols provided by local database 110.
Automated reagent dispensing system 100 may optionally include one or more printers 118. Printer 118 may communicate directly with control computer 102, as shown, or directly with stainers 104. Furthermore, stainers 104 may each have a dedicated printer 118 that may be integrated into the stainers or free-standing, or multiple stainers 104 may share one or more printers.
Automated reagent dispensing system 100 may also include a hand-held or desktop scanner 120 for reading identifiers that may be included throughout the system components (e.g., on microscope slides, trays, reagent containers, etc.). Any type of scanner 120 may be utilized that is capable of interpreting the identifiers. For example, scanner 120 may be an RFID scanner, a 2D or 3D barcode scanner, or any other type of scanner known in the art. Scanner 120 may communicate directly with control computer 102 or stainers 104 and each component may have a dedicated scanner.
The system may also be powered by an uninterruptible power supply 122. Uninterruptible power supply 122 may be used to limit the susceptibility of the system to general power failures that may invalidate tests that are interrupted. Such an interruption in power could also result in the tissue samples becoming unusable which could require gathering additional specimens. Power supply 122 may be used to power any or all of the components of automated reagent dispensing system 100.
Although control computer 102 is shown networked with multiple stainers 104 in
Referring to
Fluid dispensing apparatus 226 includes a plurality of stations 232 at which a plurality of fluid dispensing cartridges 234 may be mounted. Stations 232 include mounting apertures 236 selectively positioning a plurality of fluid dispensing cartridges 234 adjacent to an actuator assembly 238, which is used to trigger the ejection of a desired amount of a fluid, such as a secondary reagent or a de-waxing fluid, from a fluid dispenser 340 that may be integrated into fluid dispensing cartridge 234. An example of a fluid dispensing apparatus including a multiplicity of fluid dispensing cartridges is described in U.S. patent application Ser. No. 10/639,021, the content of which is hereby incorporated by reference in its entirety. Alternatively, a fluid dispensing system using tubing or pipetting may be used, such as the system described for example in U.S. Pat. No. 5,338,358.
Retaining trays 230 are positioned on tray support stations 228 and may be configured to hold microscope slides, as shown, and/or specimen containers. As shown in
Preferably, fluid dispensing apparatus 226 and retaining trays 230 are movable with respect to one another so that cartridges 234 may be positioned to dispense fluids on any desired tray 230. Any combination of movability of fluid dispensing apparatus 226 and retaining trays 230 may be utilized. For example, both fluid dispensing apparatus 226 and retaining trays 230 may be movable or only one may be movable and the other stationary.
Actuator assembly 238 optionally includes a plurality of actuators 242, 243, 244, which may be used to selectively dispense fluid onto respective rows 246, 247, 248, of retaining trays 230. In the embodiment shown, dispensing actuator 242 is configured to dispense fluids onto retaining trays 230 disposed in row 246, dispensing actuator 243 is configured to dispense fluids onto retaining trays 230 disposed in row 247 and dispensing actuator 244 is configured to dispense fluids onto retaining trays 230 disposed in row 248. Of course, as will be understood by those of skill in the art, any number of actuators and/or slide retaining trays can be employed without departing from the scope of the present invention.
In an example of operation of stainer 104, fluid dispensing apparatus 226 is rotated so that individual cartridges 234 are selectively positioned adjacent actuators 242, 243, 244 of actuator assembly 238. Alternatively, an actuator may be positioned adjacent to each cartridge 234 such that rotation of the fluid dispensing apparatus 226 with respect to actuator assembly 238 is not required. Actuator assembly 238 may be any activation device that triggers cartridge 234 to emit a controlled amount of fluid. Preferably, fluid dispensing apparatus 226 may be both translated and rotated with respect to retaining trays 230 so that an individual cartridge 234 can be selectively positioned above any retaining tray 230. After cartridge 234 is positioned above a selected retaining tray 230, actuator assembly 238 triggers cartridge 234 to emit a controlled amount of fluid onto retaining tray 230.
In a preferred embodiment, the fluid dispensing apparatus 226 may be coupled to a support member 350 such that cartridges 234 maybe rotated with respect to actuator assembly 238. Actuator assembly 238 may be fixedly attached to support member 350, optionally beneath fluid dispensing cartridges 234. Preferably, support member 350 may be translated horizontally such that cartridges 234 can be both rotated and translated with respect to the trays 230. In this manner, any cartridge 234 can be selectively positioned above any retaining tray 230.
Retaining trays 230 preferably are mounted to tray support stations 228 on spring loaded heating/cooling pads 352, thereby providing selective and/or independent heating and/or cooling of retaining trays 230 and their associated slides and/or specimen containers. Additionally, heating/cooling pads 352 are capable of independently heating the plateau or platen region and the recess region. In an embodiment, each tray 230 has a corresponding heating and/or cooling element 352, maintaining retaining tray 230 at a particular desired temperature. In an alternative embodiment, there may be two or more heating and/or cooling elements for each retaining tray 230.
Stainer 104 optionally includes bulk fluid supply containers 354, waste fluid containers 356 and one or more fluid delivery manifolds 358. Supply containers 354 may be used to hold liquids such as water for rinsing or flushing the gap between a microscope slide, or specimen container, and platen, or plateau, 231 of a respective retaining tray 230. Fluid delivery manifold 358 preferably includes valves and switches (not shown) for directing the flow of fluids from supply containers 354, through an inlet port and conduit of manifold 358, to retaining trays 230. In addition, fluid delivery manifold 358 may include valves and switches (not shown) for directing the flow of excess fluids and waste material from fluid evacuation ports and conduits of manifold 358 into waste fluid containers 356.
Stainer 104 may also include a scanning device (not shown) for scanning identifiers included on retaining trays 230 or specimen slides or containers. The scanning device may be coupled to fluid dispensing apparatus 226, for example, so that information may be read from identifiers on retaining trays 230 as fluid dispensing apparatus 226 is translated over retaining trays 230. The scanning device may also be configured so that stations 232 for reagent cartridges 234 may be moved relative to the scanning device so that identifiers included on cartridges 234 may also be read by the scanning device.
A method of manufacturing a slide retaining tray 230 according to the principles of the present invention will now be described with respect to
The next step involves dispensing a desired quantity of reagent into reagent recess 235 (shown in
After filling the recess, it may be sealed. As illustrated diagrammatically as box 420, the next step involves sealing the recess. The recess may be sealed in any way known in the art, for example the recess may be sealed by applying tape, or another sealing material such as a meltable material that can allow the recess to become open upon melting of the reagent containing matrix. Any form of seal may be selected that can retain the reagent in place and reduce vaporization and/or fluidic flow loss. For example, a mechanical seal can be applied as discussed above.
After a reagent is loaded into the reagent recess and the recess is sealed, an identifier may be affixed to the retaining tray as shown by box 430. The identifier may be used to track the location and processing of a particular biological specimen. It may also be used to correlate a biological specimen with the reagent contained in the recess of the retaining tray so that reagent specific processing may be performed. The identifier may also contain information about the specimen, requested processing and/or requesting physician. Any type of identifier may be used such as, for example, two or three dimensional barcodes, RFID devices, scanable microchips, etc. as will be appreciated by a person having ordinary skill in the art.
Prior to initiating a procedure, specimens on retaining trays are loaded into a stainer that is included in the system. As shown in
The steps of selecting a slide, determining a reagent protocol, selecting a tray, positioning the slide on a tray and positioning the tray on the stainer may be repeated until the tray capacity of the stainer is met as indicated by box 570. For example, in an embodiment, a stainer of the present system may have a twenty-four (24) tray capacity as shown in
Additionally, an administrator setting up a user may manually limit that user's ability to perform various operations. For example, the administrator may prohibit the user from editing programs or performing manual operations. An administrator may limit the user's access to various operations through a function selection display, as shown in
After creating the user account, the user may login as illustrated diagrammatically as box 610 of
Next, the user may elect or be required to change his/her password as indicated by box 620 in
After a user has created an account, they may edit system preferences through a system setup display.
A contact information section 1130 may also be provided to enable the user to input contact information such as name, phone number, electronic mail address, web site or other information for a sales, customer support or other person associated with the system. Selectable function keys 1140 may also be presented to enable the user to save the settings and exit display 1100.
After changing the password, or if a password change request has not been received, the user may be presented with a main control display as illustrated diagrammatically as box 640 in
After detecting a start condition, an inventory procedure may be run as diagrammatically illustrated as box 1220. The inventory procedure may include the scanning procedure illustrated in
Identifiers associated with reagent cartridges are then scanned as illustrated diagrammatically as box 1350. By scanning the reagent cartridges, the system may indicate the type and quantity of a reagent present in each reagent cartridge. A determination is made regarding a cartridge condition for each reagent cartridge (box 1360). The determination may indicate a particular type of reagent contained in the cartridge and that the quantity of reagent in the cartridge such as in percentage fill of the cartridge (e.g., cartridge is seventy-five (75) percent full).
Maintaining a history of the quantity of a reagent that has been dispensed may further assist in making the determination regarding the quantity of reagent that is present in the cartridge. For example, in an embodiment, a cartridge may have a one-hundred (100) milliliter capacity for reagent and in an embodiment each time reagent is dispensed from the cartridge using the automated reagent dispensing system, one (1) milliliter of reagent is dispensed. If the history indicates that reagent has been dispensed twenty-five (25) times from the cartridge, then seventy-five (75) milliliters (or seventy-five (75) percent) of the reagent remains in the cartridge. After determining the cartridge condition, a cartridge condition signal maybe output to provide the user with an indication regarding how much and what types of reagents are stored in the cartridges (box 1370). As an example of this, a number of dispenses is designated as a maximum for each cartridge. With each dispense a mechanical or software counter is incremented, and once the maximum number is reached or exceeded, a replace signal or other indicator is provided. In a further example, a cartridge depleted signal is provided which the system understands as requiring no further usage of the cartridge, and requiring replacement. Alternatively, the cartridge can continue being used, but a warning is provided, notifying an operator that a fresh cartridge should be installed. As a further example, the maximum number of dispenses for each cartridge is pre-programmed in a computer memory, or alternatively is noted on a readable (machine or human) indicator on a cartridge label. Different number of maximum dispenses can be set for different cartridges or different volume of dispensing chambers on particular cartridges.
If a determination is made that a cartridge is empty or that the cartridge contains an insufficient amount of reagent to perform a predetermined staining process, the automated reagent dispensing system may await an override or replacement signal as diagrammatically illustrated as box 1380. The override signal indicates that the user desires to continue with a staining process regardless of the cartridge conditions. The replacement signal indicates that one or more of the cartridges having an insufficient amount of reagent have been filled or replaced. In addition, the system may scan the bulk solution and waste containers to determine whether they require refilling, emptying or replacement.
In another embodiment of an initialization process, shown in
A scanner of the automated reagent dispensing system is returned to a home position, provided the scanner is not already located at the home position, shown diagrammatically as box 1425. The scanner then scans the cartridges (box 1430). The cartridges are scanned to determine a number of cartridges present and what reagents are present in the cartridges. After scanning the cartridges, the scanner may be returned to the home position, illustrated diagrammatically as box 1435. The containers provided in the automated reagent dispensing system are then scanned to determine a number of containers and which reagents are present (box 1440).
Based on the scan of the containers, a determination is made regarding whether each of the containers has an acceptable fluid level, illustrated diagrammatically as box 1445. If a determination is made that the fluid levels in each of the containers is acceptable, a ready signal may be output to, for example, a controller of the automated reagent dispensing system (box 1450). The ready signal indicates that the automated reagent dispensing system is ready to operate and the staining protocols are run (box 1455).
If a determination is made that the fluid level in any of the containers is not acceptable, a container condition signal may be output as illustrated diagrammatically as box 1460. The automated reagent dispensing system may then await an override or replacement signal as described in further detail above with reference to
The information that is gathered during the inventory procedures may be stored in one or more databases either locally or externally. The databases may be formatted through displays that allow the user to input and organize data.
As mentioned above, after the system has run the inventory procedures it may display the gathered information through a main control display. Examples of main control displays 1700, 1800 are shown in
The main control display preferably enables the user to view which trays and cartridges are in use, an amount of reagent available, an amount of waste collected, pause operation of the automated reagent dispensing system, add/remove trays/cartridges from operation, and other desired functions. The main control display preferably also provides a status of a staining protocol being run or the last staining protocol run. Additional information such as tray and/or slide information obtained by scanning associated identifiers may also be displayed.
Upon completion of the inventory procedure, the automated reagent dispensing system may receive instruction sequences from a controller as diagrammatically illustrated as box 1130. The instruction sequences define one or more staining processes to be applied to the specimens contained on the slides, or in the containers, provided on the retaining trays. The staining processes, as described above, identify the type and quantity of each reagent that will be applied to each specimen over a specified period.
During the process of using the system shown in
After the slide information is scanned and displayed through the main control display. The user may be presented with displays that allow them to manually edit the gathered information.
After receiving a run program request, the automated reagent dispensing system runs the program request as illustrated diagrammatically as box 660 and as further detailed in
While the staining protocols are run, the automated reagent dispensing system determines whether an interrupt signal has been received, as indicated by box 1250. An interrupt signal may be caused by, for example, opening of the cover of the automated reagent dispensing system, a command received from the controller or other event. If an interrupt signal has been received, the automated reagent dispensing system stops processing as diagrammatically illustrated as box 1260. A determination is then made regarding whether a resume processing signal has been received (box 1270). If a resume processing signal has not been received, the automated reagent dispensing system continues to stall processing (box 1260). If a resume processing signal has been received, however, the automated reagent dispensing system continues to run the staining protocols as diagrammatically shown by box 1240.
If an interrupt signal has not been received, a determination is made whether processing has been completed, as indicated by box 1280. Processing may include completing all staining protocols for each of the tissue samples provided in the automated reagent dispensing system.
If the processing has not been completed, the automated reagent dispensing system continues to run the staining protocols as diagrammatically shown as box 1240. If a determination is made that processing is complete, a processing complete signal may be output to a controller (box 1290) and the automated reagent dispensing system stops processing as diagrammatically illustrated as box 1260.
The automated reagent dispensing system then determines whether a resume signal has been received as shown diagrammatically as box 2160. A resume signal may be caused by closing the cover or a command output by a controller as described above. If a resume signal has not been received, the automated reagent dispensing system continues to position the cartridge carousel or holder at a home position (box 2140). If, however, a resume signal has been received, the automated reagent dispensing system resumes the staining protocol(s) as illustrated diagrammatically as box 2170.
In another embodiment, the process may be fully automated.
One or more status reports may be transmitted from the automated reagent dispensing system to, for example, a central controller such as a personal computer or other controller, as illustrated by box 2260. Status reports may be transmitted automatically, for example, on a periodic basis, or manually upon request by a user using the central controller. Upon receiving the status reports, the central controller may display the reports as diagrammatically illustrated by box 2270.
Referring back to
Methods of processing tissue samples in accordance with the present invention may include various steps. In an embodiment, a method of processing a tissue sample using a slide retaining tray in accordance with the present invention is shown in to
As illustrated diagrammatically as box 2410, the next step involves optionally swiping a bar code on a slide or tray. It should be noted that such a step is not necessary, and alternatively, no slide data may be read or input, or slide data may be input manually. As illustrated diagrammatically as box 2420, the next step involves pulling the seal from the tray, thereby exposing the recess and reagent therein. Referring to box 2430, the next step involves positioning the slide on the tray. Preferably, the slide is positioned such that the tissue sample is disposed between the slide and a platen. As illustrated diagrammatically as box 2440, the next step involves optionally positioning the slide retaining tray on a spring loaded heating/cooling pad.
As illustrated diagrammatically as box 2450, the next step involves liquefying a reagent matrix (i.e., the gel). This step may include the step of heating the matrix to form a melt. Alternatively, the matrix may be soluble in a solvent, which is added to the recess to dissolve it. Thus, the step of liquefying the matrix alternatively may include the step of dissolving the gel using a solvent. Referring to box 2460, the next step involves flowing the liquefied reagent matrix over a drip surface into a gap, or reaction chamber, between the platen and the slide. This step may be accomplished with the assistance of gravity.
Referring to box 2470, the next step optionally involves flushing the gap with wash fluids to prepare the tissue sample for subsequent tissue processing steps. As illustrated diagrammatically as box 2480, the next step involves optionally dispensing non-primary reagents from the fluid dispensing apparatus onto the drip surface of the retaining tray. Finally, referring to box 2490, the next step involves drawing waste and excess fluid through a fluid return conduit into a waste reservoir.
With further reference to
The processing procedure also includes dispensing reagents from the cartridges as illustrated diagrammatically as box 2520. The reagent may be dispensed from the cartridge using, for example, a pump. The cartridges may be provided with a pump that is actuated by a solenoid. If a particular reagent is required to be dispensed, the automated reagent dispensing system actuates the solenoid associated with that cartridge by transmitting a signal to the solenoid. The solenoid pushes the pump and causes a predetermined amount of reagent to be dispensed from the cartridge. Preferably, the reagent is dispensed at desired times and according to a staining protocol.
The automated reagent dispensing system may also dispense reagents from tray reagent containers, or recesses, as shown diagrammatically as box 2530.
Upon completion of a processing procedure, evacuation ports associated with the trays may be activated as illustrated diagrammatically as box 2540. The evacuation ports may be, for example, holes provided in the trays. A vacuum may be applied to the tray that causes reagent located on the tray to be sucked into a waste conduit. According to an embodiment of the present invention, the waste may be divided into hazardous and non-hazardous waste with each going into a respective waste container.
The system may also allow for an audit logging procedure to be performed, as shown in
Referring to
The display 2900 may also include a number of cycles section 2930, variability section 2940, and a hold time section 2950. The number of cycles section 2930 enables the user to indicate a minimum, maximum, and/or default number of cycles for the program to perform. The variability section 2940 enables the user to indicate a minimum, maximum, and/or default number for variability within the program. The hold time section 2950 enables the user to indicate a minimum, maximum, and/or default holding time for the program. The holding time may be indicated in seconds, minutes, hours or any other increment. The macro, number of cycles, variability, and hold time sections 2920, 2930, 2940, and 2950, respectively, may each have function keys 2960 associated therewith. The function keys 2960 may enable the user to add/edit/clear all/delete/undo information input into one or more of the macro, number of cycles, variability, and hold time sections 2920, 2930, 2940, and 2950, respectively.
The display 2900 may also include an information section 2970 and program type section 2980. The information section 2970 may include information relating to the program. The information may include, for example, step, function, reagent, hold time, platen temperature, and variability. The program type section 2980 may enable the user to select a particular program to run. The user may elect to use a particular program as the default program or allow the user to select a program during worklist development.
Data fields 3110 may also be provided for each reagent associated with the macro. Data fields 3110 regarding reagent information may provide information pertaining to cartridge reagent identifier, cartridge reagent abbreviated name, bulk solution identifier and bulk solution abbreviated name. Other information may also be provided in data fields 3110 such as, for example, step sequence number, action, total units, platen temperature, pellet recess temperature, cycle step, criticality factor, and time.
An information section 3120 may be provided that provides additional information regarding one or more of the data fields 3110. Selectable function keys 3130 may also be presented to enable the user to create/edit/delete/save a particular macro, undo/clear information input, and exit the display 3100.
The user may use a send commands display as shown in
Information sections 3520, 3620 maybe provided that provides additional information regarding one or more of the data fields 3510, 3610. Selectable function keys 3530, 3630 may also be presented to enable the user to save a particular tray reagent and exit the displays 3500, 3600. Furthermore, tray reagent category selectors 3540, 3640 may also be provided. The tray reagent category selectors 3540, 3640 enable the user to indicate whether the tray reagent is a basic tray reagent or a user-defined tray reagent.
Information sections 3820, 3920 maybe provided that provides additional information regarding one or more of the data fields 3810, 3910. Selectable function keys 3830, 3930 may also be presented to enable the user to save a particular cartridge reagent and exit the displays 3800, 3900. Furthermore, cartridge reagent category selectors 3840, 3940 may also be provided. The cartridge reagent category selectors 3840, 3940 enable the user to indicate whether the cartridge reagent is a basic cartridge reagent or a user-defined cartridge reagent.
Information sections 4120, 4220 may be provided that provides additional information regarding one or more of the data fields 4110, 4210. Selectable function keys 4130, 4230 may also be presented to enable the user to save a particular bulk solution and exit the displays 4100, 4200. Furthermore, bulk solution category selectors 4140, 4240 may also be provided. The bulk solution category selectors 4140, 4240 enable the user to indicate whether the bulk solution is a basic bulk solution or a user-defined bulk solution.
The display 4500 may also include selectable function keys 4550 that perform a desired function when selected. The keys 4550 may enable users to display slide details, adjust program variables, delete entry, print worklist, and close worklist. The keys 4550 may be used in conjunction with information provided in the table 4520. For example, the user may select information related to a particular slide. This selection may be indicated by having a row in which the information lies be highlighted. The user may then select one of the keys 4550 to perform a particular function related to the information selected. For example, the user may select information regarding a particular slide and choose to delete information regarding that slide. The user then selects delete entry key 4550 to delete the information regarding that slide. Optionally, the user may be presented with a confirmation message requesting confirmation from the user that the information selected is to be deleted.
The user may also elect to begin a particular program at a later time. The user may use a delayed start function to achieve this. If the user desires to begin a particular program at a later time, the user may be presented with a delayed start display as shown in
The display 4700 may also include reports fields 4720, schedule fields 4730, days fields 4740, interval fields 4750, and time fields 4760. The report fields 4720 may provide a list of reports for which to automatically schedule to print a particular report. For example, the user may select to automatically print reports for overdue worklists, workload statistics, product expiry warning, overdue maintenance, run history, and other reports. The schedule fields section 4730 may provide pull-down menus, radio buttons, check boxes or other selectable option to disable or enable scheduled auto prints for a particular report. The day fields 4740, interval fields 4750, and time fields 4760 may also enable the user to select a day, interval, and time on which to automatically print a particular report. Selectable function keys 4770 may also be presented to enable the user to save an auto print schedule and exit the display 4700.
The user may also request that debug commands be run and that response data be saved to a particular location. The user may request the debug commands be run using a debug system display as shown in
Referring to
The display 5400 may also include a step data fields section 5420 that includes one or more fields regarding step data that may be included in the report. The step data may include, for example, step sequence number, reagent/primary antibody/probe, time, platen temperature, pellet recess temperature, and criticality factor. Selectable function keys 5430 may also be presented to enable the user to restore or save a program report setup and exit the display 5400.
The display 5600 may also include a step data fields section 5620 that includes one or more fields regarding step data that may be included in the report. The step data may include, for example, step sequence number, time, platen temperature, pellet recess temperature, criticality factor, and cycle step (on/off). Selectable function keys 5630 may also be presented to enable the user to restore or save a macro report setup and exit the display 5600.
Finally, the user may be presented with a screen that allows them to manually print any of the reports described above, as indicated in
Thus, it is seen that an automated reagent dispensing system and method is provided. One skilled in the art will appreciate that the present invention can be practiced by other than the various embodiments and preferred embodiments, which are presented in this description for purposes of illustration and not of limitation, and the present invention is limited only by the claims that follow. It is noted that equivalents for the particular embodiments discussed in this description may practice the invention as well.
Priority is claimed to U.S. Provisional Patent Application Ser. No. 60/652,432, filed Feb. 11, 2005, and entitled “Automated Reagent Dispensing System and Method of Operation”; and U.S. Provisional Patent Application Ser. No. 60/678,682, filed May 6, 2005, and entitled “Automated Reagent Dispensing System and Method of Operation,” the contents of both which are incorporated in their entireties herein by reference. This application is also a continuation-in-part of U.S. patent application Ser. No. 10/639,021, filed on Aug. 11, 2003, which issued on Feb. 17, 2005 as U.S. Pat. No. 7,501,283, and entitled “Fluid Dispensing Apparatus”, which is incorporated in its entirety herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
1621097 | Zammataro | Mar 1927 | A |
2709025 | Scott | May 1955 | A |
2772817 | Jauch | Dec 1956 | A |
3008611 | Mancusi, Jr. | Nov 1961 | A |
3066832 | Rossetti | Dec 1962 | A |
3116747 | Cowles et al. | Jan 1964 | A |
3232496 | Rockwell, Jr. et al. | Feb 1966 | A |
3294290 | Erickson et al. | Dec 1966 | A |
3504699 | Grise | Apr 1970 | A |
3741439 | Vehrs | Jun 1973 | A |
3752366 | Lawrence, Jr. | Aug 1973 | A |
3794213 | Schwartzman | Feb 1974 | A |
3870201 | Asplund | Mar 1975 | A |
3881641 | Pliml, Jr. et al. | May 1975 | A |
3904079 | Kross | Sep 1975 | A |
3987938 | Cooprider et al. | Oct 1976 | A |
4018363 | Cassia | Apr 1977 | A |
4025241 | Clemens | May 1977 | A |
4039775 | Andra | Aug 1977 | A |
4067414 | Funke | Jan 1978 | A |
4099483 | Henderson | Jul 1978 | A |
4130224 | Norman et al. | Dec 1978 | A |
4134853 | Ehrlich et al. | Jan 1979 | A |
4135649 | Baldwin et al. | Jan 1979 | A |
4149573 | Cassia | Apr 1979 | A |
4149633 | Nilson | Apr 1979 | A |
4199558 | Henderson | Apr 1980 | A |
4256242 | Christine | Mar 1981 | A |
4258759 | Achen | Mar 1981 | A |
4334640 | van Overbruggen et al. | Jun 1982 | A |
4345627 | Cassia | Aug 1982 | A |
4349133 | Christine | Sep 1982 | A |
4356727 | Brown et al. | Nov 1982 | A |
4394938 | Frassanito | Jul 1983 | A |
4440323 | Benson | Apr 1984 | A |
4513885 | Hogan | Apr 1985 | A |
4515294 | Udall | May 1985 | A |
4561571 | Chen | Dec 1985 | A |
4573612 | Maddison et al. | Mar 1986 | A |
4601411 | van Overbruggen | Jul 1986 | A |
4604964 | Gordon et al. | Aug 1986 | A |
4607764 | Christine | Aug 1986 | A |
4615476 | Hobbs et al. | Oct 1986 | A |
4621749 | Kanfer | Nov 1986 | A |
4646945 | Steiner et al. | Mar 1987 | A |
4651898 | Bell | Mar 1987 | A |
4667854 | McDermott et al. | May 1987 | A |
4673109 | Cassia | Jun 1987 | A |
4678752 | Thorne et al. | Jul 1987 | A |
4722372 | Hoffman et al. | Feb 1988 | A |
4731335 | Brigati | Mar 1988 | A |
4741461 | Williamson et al. | May 1988 | A |
4741898 | Mallik et al. | May 1988 | A |
4764342 | Kelln et al. | Aug 1988 | A |
4776495 | Vignot | Oct 1988 | A |
4790640 | Nason | Dec 1988 | A |
4798311 | Workum | Jan 1989 | A |
4801431 | Cuomo et al. | Jan 1989 | A |
4834019 | Gordon et al. | May 1989 | A |
4838457 | Swahl et al. | Jun 1989 | A |
4846636 | Danby et al. | Jul 1989 | A |
4849176 | Sakagami | Jul 1989 | A |
4867347 | Wass et al. | Sep 1989 | A |
4880149 | Scholefield et al. | Nov 1989 | A |
4886192 | Cassia | Dec 1989 | A |
4895276 | Maldonado | Jan 1990 | A |
4917265 | Chiang | Apr 1990 | A |
4921136 | Roggenburg, Jr. | May 1990 | A |
4927061 | Leigh et al. | May 1990 | A |
4932624 | Holm | Jun 1990 | A |
4946076 | Hackmann et al. | Aug 1990 | A |
4955512 | Sharples | Sep 1990 | A |
4961508 | Weimer et al. | Oct 1990 | A |
4967940 | Blette et al. | Nov 1990 | A |
4969581 | Seifert et al. | Nov 1990 | A |
4972978 | DeLuca | Nov 1990 | A |
4974754 | Wirz | Dec 1990 | A |
4978036 | Burd | Dec 1990 | A |
4978502 | Dole et al. | Dec 1990 | A |
4985206 | Bowman et al. | Jan 1991 | A |
5002736 | Babbitt et al. | Mar 1991 | A |
5033656 | Blette et al. | Jul 1991 | A |
5033943 | Durrum et al. | Jul 1991 | A |
5035350 | Blette et al. | Jul 1991 | A |
5042691 | Maldonado | Aug 1991 | A |
5068091 | Toya | Nov 1991 | A |
5073504 | Bogen | Dec 1991 | A |
5082150 | Steiner et al. | Jan 1992 | A |
5105992 | Fender et al. | Apr 1992 | A |
5225325 | Miller et al. | Jul 1993 | A |
5232664 | Krawzak et al. | Aug 1993 | A |
5242081 | van der Heyden et al. | Sep 1993 | A |
5242083 | Christine et al. | Sep 1993 | A |
5244787 | Key et al. | Sep 1993 | A |
5252293 | Drbal et al. | Oct 1993 | A |
5253774 | Honig et al. | Oct 1993 | A |
5255822 | Mease et al. | Oct 1993 | A |
5265770 | Matkovich et al. | Nov 1993 | A |
5273905 | Muller et al. | Dec 1993 | A |
5275309 | Baron et al. | Jan 1994 | A |
5316452 | Bogen et al. | May 1994 | A |
5322771 | Rybski et al. | Jun 1994 | A |
5338358 | Mizusawa et al. | Aug 1994 | A |
5355439 | Bernstein et al. | Oct 1994 | A |
5356039 | Christine et al. | Oct 1994 | A |
5390822 | Lataix | Feb 1995 | A |
5405580 | Palmer | Apr 1995 | A |
5418138 | Miller et al. | May 1995 | A |
5421489 | Holzner, Sr. et al. | Jun 1995 | A |
5424036 | Ushikubo | Jun 1995 | A |
5425918 | Healey et al. | Jun 1995 | A |
5433351 | Okuyama et al. | Jul 1995 | A |
5439645 | Saralegui | Aug 1995 | A |
5439649 | Tseung et al. | Aug 1995 | A |
5464125 | Daansen | Nov 1995 | A |
5474212 | Ichikawa et al. | Dec 1995 | A |
5492247 | Shu et al. | Feb 1996 | A |
5501372 | Daansen | Mar 1996 | A |
5525300 | Danssaert et al. | Jun 1996 | A |
5534114 | Cutright et al. | Jul 1996 | A |
5561556 | Weissman et al. | Oct 1996 | A |
5578452 | Shi et al. | Nov 1996 | A |
5579945 | Ichikawa et al. | Dec 1996 | A |
5580523 | Bard | Dec 1996 | A |
5595707 | Copeland et al. | Jan 1997 | A |
5597093 | Lee | Jan 1997 | A |
5602674 | Weissman et al. | Feb 1997 | A |
5609822 | Carey et al. | Mar 1997 | A |
5626262 | Fitten et al. | May 1997 | A |
5639423 | Northrup et al. | Jun 1997 | A |
5645114 | Bogen et al. | Jul 1997 | A |
5650327 | Copeland et al. | Jul 1997 | A |
5654199 | Copeland et al. | Aug 1997 | A |
5654200 | Copeland et al. | Aug 1997 | A |
5675715 | Bernstein et al. | Oct 1997 | A |
5700346 | Edwards | Dec 1997 | A |
5810204 | Devlin et al. | Sep 1998 | A |
5819842 | Potter et al. | Oct 1998 | A |
5836482 | Ophardt et al. | Nov 1998 | A |
5839091 | Rhett et al. | Nov 1998 | A |
5843700 | Kerrod et al. | Dec 1998 | A |
5846396 | Zanzucchi et al. | Dec 1998 | A |
5851488 | Saul et al. | Dec 1998 | A |
5855302 | Fisscher | Jan 1999 | A |
5857595 | Nilson | Jan 1999 | A |
5885530 | Babson et al. | Mar 1999 | A |
5909828 | Salisbury | Jun 1999 | A |
5938414 | Kayahara et al. | Aug 1999 | A |
5947167 | Bogen et al. | Sep 1999 | A |
5948359 | Kalra et al. | Sep 1999 | A |
5950874 | Sindoni | Sep 1999 | A |
5950878 | Wade et al. | Sep 1999 | A |
5954167 | Richardson et al. | Sep 1999 | A |
5958341 | Chu | Sep 1999 | A |
5964454 | Volpel | Oct 1999 | A |
5965454 | Farmilo et al. | Oct 1999 | A |
5968731 | Layne et al. | Oct 1999 | A |
5971223 | Fisscher | Oct 1999 | A |
6001309 | Gamble et al. | Dec 1999 | A |
6012613 | Chen | Jan 2000 | A |
6017495 | Ljungmann | Jan 2000 | A |
6020995 | Dreyer et al. | Feb 2000 | A |
6045759 | Ford et al. | Apr 2000 | A |
6068162 | De Winter et al. | May 2000 | A |
6076583 | Edwards | Jun 2000 | A |
6092695 | Loeffler | Jul 2000 | A |
6093574 | Druyor-Sanchez et al. | Jul 2000 | A |
6096271 | Bogen et al. | Aug 2000 | A |
6131773 | Wade et al. | Oct 2000 | A |
6142343 | Wade et al. | Nov 2000 | A |
6152330 | Polan | Nov 2000 | A |
6180061 | Bogen et al. | Jan 2001 | B1 |
6183693 | Bogen et al. | Feb 2001 | B1 |
6189740 | Wade et al. | Feb 2001 | B1 |
6192945 | Ford et al. | Feb 2001 | B1 |
6206238 | Ophardt | Mar 2001 | B1 |
6216916 | Maddox et al. | Apr 2001 | B1 |
6238910 | Custance et al. | May 2001 | B1 |
6244474 | Loeffler | Jun 2001 | B1 |
6259956 | Myers et al. | Jul 2001 | B1 |
6273298 | Post | Aug 2001 | B1 |
6286725 | Gerber | Sep 2001 | B1 |
6296809 | Richards et al. | Oct 2001 | B1 |
6335166 | Ammann et al. | Jan 2002 | B1 |
6343716 | Baudin et al. | Feb 2002 | B1 |
6349264 | Rhett et al. | Feb 2002 | B1 |
6352861 | Copeland et al. | Mar 2002 | B1 |
6387326 | Edwards et al. | May 2002 | B1 |
6415961 | Bonningue | Jul 2002 | B2 |
6416713 | Ford et al. | Jul 2002 | B1 |
6451551 | Zhan et al. | Sep 2002 | B1 |
6472217 | Richards et al. | Oct 2002 | B1 |
6489171 | Aghassi et al. | Dec 2002 | B1 |
6495106 | Kalra et al. | Dec 2002 | B1 |
6516620 | Lang | Feb 2003 | B2 |
6534008 | Angros | Mar 2003 | B1 |
6540117 | Powling | Apr 2003 | B2 |
6541261 | Bogen et al. | Apr 2003 | B1 |
6543652 | Kelder et al. | Apr 2003 | B1 |
6544798 | Christensen et al. | Apr 2003 | B1 |
6553145 | Kang et al. | Apr 2003 | B1 |
6568561 | Studer et al. | May 2003 | B2 |
6580056 | Tacha | Jun 2003 | B1 |
6582962 | Richards et al. | Jun 2003 | B1 |
6594537 | Bernstein et al. | Jul 2003 | B1 |
6605213 | Ammann et al. | Aug 2003 | B1 |
6607103 | Gerenraich et al. | Aug 2003 | B2 |
6632598 | Zhang et al. | Oct 2003 | B1 |
6635225 | Thiem et al. | Oct 2003 | B1 |
6656428 | Clark et al. | Dec 2003 | B1 |
6673620 | Loeffler et al. | Jan 2004 | B1 |
6703247 | Chu | Mar 2004 | B1 |
6707873 | Thompson et al. | Mar 2004 | B2 |
6720888 | Eagleson et al. | Apr 2004 | B2 |
6729502 | Lewis et al. | May 2004 | B2 |
6735531 | Rhett et al. | May 2004 | B2 |
6746851 | Tseung et al. | Jun 2004 | B1 |
6758360 | Van Giezen et al. | Jul 2004 | B2 |
6783733 | Bogen et al. | Aug 2004 | B2 |
6805264 | Houvras | Oct 2004 | B2 |
6814262 | Adams et al. | Nov 2004 | B1 |
6827900 | Thiem et al. | Dec 2004 | B2 |
6827901 | Copeland et al. | Dec 2004 | B2 |
6855292 | Angros | Feb 2005 | B2 |
6855552 | Towne et al. | Feb 2005 | B2 |
6855559 | Christensen et al. | Feb 2005 | B1 |
6899283 | Ohnishi et al. | May 2005 | B2 |
6943029 | Copeland et al. | Sep 2005 | B2 |
6945128 | Ford et al. | Sep 2005 | B2 |
6991934 | Walton et al. | Jan 2006 | B2 |
6998270 | Tseung et al. | Feb 2006 | B2 |
7004356 | Sayers | Feb 2006 | B1 |
7007824 | Danby et al. | Mar 2006 | B2 |
7025937 | Plank | Apr 2006 | B2 |
7057808 | Dooling | Jun 2006 | B2 |
7070951 | Zhang et al. | Jul 2006 | B2 |
7083106 | Albany | Aug 2006 | B2 |
7118918 | Copeland et al. | Oct 2006 | B2 |
7156814 | Williamson et al. | Jan 2007 | B1 |
7165722 | Shafer et al. | Jan 2007 | B2 |
7169601 | Northrup | Jan 2007 | B1 |
7178416 | Whelan et al. | Feb 2007 | B2 |
7179424 | Williamson, IV et al. | Feb 2007 | B2 |
7187286 | Morris et al. | Mar 2007 | B2 |
7199712 | Tafas et al. | Apr 2007 | B2 |
7201295 | Sitzberger | Apr 2007 | B1 |
7209042 | Martin et al. | Apr 2007 | B2 |
7217392 | Bogen et al. | May 2007 | B2 |
7220589 | Richards et al. | May 2007 | B2 |
7226788 | De La Torre-Bueno | Jun 2007 | B2 |
7233250 | Forster | Jun 2007 | B2 |
7250301 | Angros | Jul 2007 | B2 |
7264142 | Py | Sep 2007 | B2 |
7270785 | Lemme et al. | Sep 2007 | B1 |
7275682 | Excoffier et al. | Oct 2007 | B2 |
7278554 | Armstrong | Oct 2007 | B2 |
7294478 | Hinchcliffe | Nov 2007 | B1 |
7303725 | Reinhardt et al. | Dec 2007 | B2 |
7314238 | Robert | Jan 2008 | B2 |
7323491 | Lohray et al. | Jan 2008 | B2 |
7338803 | Mizzer et al. | Mar 2008 | B2 |
7378055 | Lemme et al. | May 2008 | B2 |
7382258 | Oldham et al. | Jun 2008 | B2 |
7395974 | Albany | Jul 2008 | B2 |
7400983 | Feingold et al. | Jul 2008 | B2 |
7405056 | Lam et al. | Jul 2008 | B2 |
7425306 | Kram | Sep 2008 | B1 |
7435381 | Pugia et al. | Oct 2008 | B2 |
7435383 | Tseung et al. | Oct 2008 | B2 |
7468161 | Reinhardt et al. | Dec 2008 | B2 |
7470401 | Morales | Dec 2008 | B2 |
7470541 | Copeland et al. | Dec 2008 | B2 |
7476362 | Angros | Jan 2009 | B2 |
7501283 | Hersch et al. | Mar 2009 | B2 |
7553672 | Bogen | Jun 2009 | B2 |
7584019 | Feingold et al. | Sep 2009 | B2 |
7593787 | Feingold et al. | Sep 2009 | B2 |
7603201 | Feingold et al. | Oct 2009 | B2 |
7622077 | Angros | Nov 2009 | B2 |
7632461 | Angros | Dec 2009 | B2 |
7639139 | Tafas et al. | Dec 2009 | B2 |
7642093 | Tseung et al. | Jan 2010 | B2 |
7651010 | Orzech et al. | Jan 2010 | B2 |
7665360 | Kurihara | Feb 2010 | B2 |
7677417 | Leiner et al. | Mar 2010 | B2 |
7718435 | Bogen et al. | May 2010 | B1 |
7722811 | Konrad et al. | May 2010 | B2 |
7735694 | Brown et al. | Jun 2010 | B2 |
7744817 | Bui | Jun 2010 | B2 |
7760428 | Sieckmann | Jul 2010 | B2 |
7806301 | Ciavarella et al. | Oct 2010 | B1 |
7838283 | Erickson et al. | Nov 2010 | B2 |
7850912 | Favuzzi et al. | Dec 2010 | B2 |
7861890 | McGill | Jan 2011 | B2 |
7880617 | Morris et al. | Feb 2011 | B2 |
7887755 | Mingerink et al. | Feb 2011 | B2 |
7897106 | Angros | Mar 2011 | B2 |
7901941 | Tseung et al. | Mar 2011 | B2 |
7922986 | Byrnard et al. | Apr 2011 | B2 |
7937228 | Feingold et al. | May 2011 | B2 |
7951612 | Angros | May 2011 | B2 |
7960178 | Key et al. | Jun 2011 | B2 |
7980425 | Baron et al. | Jul 2011 | B2 |
8007720 | Angros | Aug 2011 | B2 |
8007721 | Angros | Aug 2011 | B2 |
8039262 | Konrad et al. | Oct 2011 | B2 |
8052927 | Angros | Nov 2011 | B2 |
8058010 | Erickson et al. | Nov 2011 | B2 |
8071023 | Angros | Dec 2011 | B2 |
8071026 | Rapp et al. | Dec 2011 | B2 |
8092742 | Angros | Jan 2012 | B2 |
8118183 | Iwahashi et al. | Feb 2012 | B2 |
8137619 | Ford et al. | Mar 2012 | B2 |
8142739 | Tseung et al. | Mar 2012 | B2 |
8216846 | Ljungmann et al. | Jul 2012 | B2 |
8236255 | Takayama et al. | Aug 2012 | B2 |
8257968 | Sweet et al. | Sep 2012 | B2 |
8283176 | Bland et al. | Oct 2012 | B2 |
8288086 | Metzner et al. | Oct 2012 | B2 |
8298815 | Buchanan et al. | Oct 2012 | B2 |
8315899 | Samuhel et al. | Nov 2012 | B2 |
8386195 | Feingold et al. | Feb 2013 | B2 |
8394322 | Windeyer et al. | Mar 2013 | B2 |
8394635 | Key et al. | Mar 2013 | B2 |
8396669 | Cocks | Mar 2013 | B2 |
8486714 | Favuzzi et al. | Jul 2013 | B2 |
8529836 | Winther et al. | Sep 2013 | B2 |
8554372 | Windeyer et al. | Oct 2013 | B2 |
8585985 | Lihl et al. | Nov 2013 | B2 |
8609023 | Druyor-Sanchez et al. | Dec 2013 | B1 |
8663978 | Sweet et al. | Mar 2014 | B2 |
8673642 | Key et al. | Mar 2014 | B2 |
8676509 | De La Torre-Bueno | Mar 2014 | B2 |
8887964 | Jokitalo et al. | Nov 2014 | B2 |
8969086 | Key et al. | Mar 2015 | B2 |
8969087 | Bland et al. | Mar 2015 | B2 |
20010044603 | Harrold | Nov 2001 | A1 |
20020013194 | Kitano et al. | Jan 2002 | A1 |
20020079318 | Wurzinger | Jun 2002 | A1 |
20020110494 | Lemme et al. | Aug 2002 | A1 |
20020114733 | Copeland et al. | Aug 2002 | A1 |
20020182115 | Aghassi et al. | Dec 2002 | A1 |
20020192806 | Custance et al. | Dec 2002 | A1 |
20030100043 | Kalra et al. | May 2003 | A1 |
20030157545 | Jevons et al. | Aug 2003 | A1 |
20030203493 | Lemme et al. | Oct 2003 | A1 |
20040033163 | Tseung et al. | Feb 2004 | A1 |
20040033169 | Shah | Feb 2004 | A1 |
20040091395 | Ward et al. | May 2004 | A1 |
20040120862 | Lang et al. | Jun 2004 | A1 |
20040191128 | Bogen et al. | Sep 2004 | A1 |
20040197230 | Lemme et al. | Oct 2004 | A1 |
20040266015 | Favuzzi et al. | Dec 2004 | A1 |
20050019902 | Mathies et al. | Jan 2005 | A1 |
20050035156 | Hersch et al. | Feb 2005 | A1 |
20050064535 | Favuzzi et al. | Mar 2005 | A1 |
20050135972 | Lemme et al. | Jun 2005 | A1 |
20050150911 | Bach | Jul 2005 | A1 |
20050153453 | Copeland et al. | Jul 2005 | A1 |
20050164374 | Kram | Jul 2005 | A1 |
20050186114 | Reinhardt et al. | Aug 2005 | A1 |
20050191214 | Tseung et al. | Sep 2005 | A1 |
20050250211 | Reinhardt et al. | Nov 2005 | A1 |
20050281711 | Testa et al. | Dec 2005 | A1 |
20060019332 | Zhang et al. | Jan 2006 | A1 |
20060040341 | Bland et al. | Feb 2006 | A1 |
20060045806 | Winther et al. | Mar 2006 | A1 |
20060049208 | Daansen | Mar 2006 | A1 |
20060063265 | Welcher et al. | Mar 2006 | A1 |
20060088928 | Sweet et al. | Apr 2006 | A1 |
20060088940 | Feingold et al. | Apr 2006 | A1 |
20060105359 | Favuzzi et al. | May 2006 | A1 |
20060120921 | Elliot et al. | Jun 2006 | A1 |
20060127283 | Tseung et al. | Jun 2006 | A1 |
20060134793 | Key et al. | Jun 2006 | A1 |
20060147351 | Falb et al. | Jul 2006 | A1 |
20060148063 | Fauzzi et al. | Jul 2006 | A1 |
20060151051 | Py et al. | Jul 2006 | A1 |
20060169719 | Bui | Aug 2006 | A1 |
20060171857 | Stead et al. | Aug 2006 | A1 |
20060172426 | Buchanan | Aug 2006 | A1 |
20060190185 | Ford et al. | Aug 2006 | A1 |
20060191952 | Kalra et al. | Aug 2006 | A1 |
20060239858 | Becker | Oct 2006 | A1 |
20060252025 | Nitta et al. | Nov 2006 | A1 |
20060263268 | Tseung et al. | Nov 2006 | A9 |
20060265133 | Cocks et al. | Nov 2006 | A1 |
20060269985 | Kitayama | Nov 2006 | A1 |
20060275889 | Angros et al. | Dec 2006 | A1 |
20070010912 | Feingold et al. | Jan 2007 | A1 |
20070038491 | Samuhel et al. | Feb 2007 | A1 |
20070068969 | Orzech et al. | Mar 2007 | A1 |
20070160494 | Sands | Jul 2007 | A1 |
20070270714 | Cushner et al. | Nov 2007 | A1 |
20070272710 | Bui | Nov 2007 | A1 |
20080035677 | Daansen | Feb 2008 | A1 |
20080102006 | Kram et al. | May 2008 | A1 |
20080118378 | Baron et al. | May 2008 | A1 |
20080135583 | Caswell et al. | Jun 2008 | A1 |
20080215625 | Veitch et al. | Sep 2008 | A1 |
20080217246 | Benn et al. | Sep 2008 | A1 |
20080226508 | Byrnard et al. | Sep 2008 | A1 |
20080235055 | Mattingly et al. | Sep 2008 | A1 |
20080254503 | Ljungmann et al. | Oct 2008 | A1 |
20080286753 | Erickson et al. | Nov 2008 | A1 |
20080305515 | Burgart et al. | Dec 2008 | A1 |
20090004691 | Erickson et al. | Jan 2009 | A1 |
20090028757 | Lihl et al. | Jan 2009 | A1 |
20090108033 | Quinn et al. | Apr 2009 | A1 |
20090241751 | Walter | Oct 2009 | A1 |
20090308887 | Woo et al. | Dec 2009 | A1 |
20090325309 | Favuzzi et al. | Dec 2009 | A1 |
20100017030 | Feingold et al. | Jan 2010 | A1 |
20100028978 | Angros | Feb 2010 | A1 |
20100068757 | Angros | Mar 2010 | A1 |
20100089921 | Ellenkamp-Van Olst et al. | Apr 2010 | A1 |
20100099133 | Egle et al. | Apr 2010 | A1 |
20100178668 | Elliot et al. | Jul 2010 | A1 |
20110056991 | Brown et al. | Mar 2011 | A1 |
20110079615 | Ophardt et al. | Apr 2011 | A1 |
20110167930 | Feingold et al. | Jul 2011 | A1 |
20110176977 | Tseung et al. | Jul 2011 | A1 |
20110269238 | Key et al. | Nov 2011 | A1 |
20110297703 | Wilson et al. | Dec 2011 | A1 |
20120003679 | Haberkorn | Jan 2012 | A1 |
20120179293 | Feingold et al. | Jul 2012 | A1 |
20120309044 | Ljungmann et al. | Dec 2012 | A1 |
20130029409 | Sweet et al. | Jan 2013 | A1 |
20130084567 | Buchanan et al. | Apr 2013 | A1 |
20130203103 | Feingold et al. | Aug 2013 | A1 |
20130217108 | Key et al. | Aug 2013 | A1 |
20130330252 | Winther et al. | Dec 2013 | A1 |
20140038232 | Key et al. | Feb 2014 | A1 |
20150031073 | Lemme et al. | Jan 2015 | A1 |
Number | Date | Country |
---|---|---|
2004266226 | Mar 2005 | AU |
2390207 | Aug 2000 | CN |
1847821 | Oct 2006 | CN |
385159 | Nov 1923 | DE |
3902476 | Aug 1990 | DE |
0185330 | Jun 1986 | EP |
0557871 | Sep 1993 | EP |
1 028 320 | Aug 2000 | EP |
2037255 | Jul 1980 | GB |
61200966 | Dec 1986 | JP |
3148067 | Jun 1991 | JP |
6-510860 | Dec 1994 | JP |
9-503060 | Mar 1997 | JP |
10-501167 | Feb 1998 | JP |
11170558 | Jun 1999 | JP |
11258243 | Sep 1999 | JP |
2000167318 | Jun 2000 | JP |
2001095495 | Apr 2001 | JP |
2001-509727 | Jul 2001 | JP |
2001-512823 | Aug 2001 | JP |
2001-522033 | Nov 2001 | JP |
2002507738 | Mar 2002 | JP |
2002510247 | Apr 2002 | JP |
2002-522065 | Jul 2002 | JP |
2003-057246 | Feb 2003 | JP |
2004-533605 | Nov 2004 | JP |
2009538426 | Nov 2009 | JP |
2010510430 | Apr 2010 | JP |
WO 9508774 | Mar 1995 | WO |
WO 9526796 | Oct 1995 | WO |
WO 9639260 | Dec 1996 | WO |
WO 9908090 | Feb 1999 | WO |
WO 9922867 | May 1999 | WO |
WO 0009650 | Feb 2000 | WO |
WO 0012994 | Mar 2000 | WO |
WO 0141918 | Jun 2001 | WO |
WO 02072264 | Sep 2002 | WO |
WO 03054553 | Jul 2003 | WO |
WO 03091710 | Nov 2003 | WO |
WO 03106033 | Dec 2003 | WO |
WO 2004059288 | Jul 2004 | WO |
WO 2004074847 | Sep 2004 | WO |
WO 2005000731 | Jan 2005 | WO |
WO-2015051295 | Apr 2015 | WO |
Entry |
---|
PCT Search Report for PCT Appln No. PCT/US04/25960, mailed Aug. 8, 2006 (10 pages). |
PCT Search Report for PCT Appln No. PCT/US2007/012400, mailed Nov. 16, 2007 (13 pages). |
Office Action for Japanese Application No. 2006-34571 dated Feb. 27, 2008 (4 pages). |
Office Action for European Application No. 06101498.1 dated Jun. 27, 2008 (9 pages). |
Office Action for Japanese Application No. 2006-354547 dated Dec. 26, 2008 (7 pages). |
Office Action for Chinese Application No. 200610007366.7 dated May 8, 2009 (21 pages). |
Sakura Fineteck U.S.A. Inc., CN Office Action dated May 10, 2010 for Chinese Appln. No. 200610007366.7. |
Sakura Fineteck U.S.A. Inc., Final office action dated May 25, 2010 for U.S. Appl. No. 11/441,668. |
English Translation of DE385159, 2 Pages. |
Sakura Finetek, Non -final Office Action mailed Aug. 2, 2011 for U.S. Appl. No. 11/441,668. |
Sakura Finetek U.S.A., Japanese office action dated Jul. 6, 2011 for JP Appln. No. 2008-141687. |
Sakura Finetek U.S.A., Sixth Office Action mailed Mar. 31, 2011 for Chinese Appln. No. 200610007366.7, 6 pages. |
Sakura Finetek U.S.A., Third Office Action mailed Jun. 9, 2011 for CN Appln. No. 200610007365.2, 6 pages. |
Sakura Finetek U.S.A., First Office Action mailed Mar. 31, 2011 for EP Appln. No. 04780745.8, 3 pages. |
Sakura Finetek, Australian Office Action mailed Jan. 3, 2012 for 2007267881., 5 pages. |
Sakura Finetek, Chinese office action dated Jan. 18, 2012 for CN 200780019204.8. |
Sakura Finetek, Japanese Office Action mailed Mar. 1, 2012 for App No. 2008-141687., 8 pages. |
Sakura Finetek, Chinese Office Action mailed Feb. 16, 2012 for Chinese App 200610004479.1., 23 pages. |
Sakura Finetek, Japanese Office Action mailed Mar. 12, 2012 for Application No. 2008-141687., 7 pages. |
Sakura Finetek, Non-Final Office Action mailed Mar. 27, 2012 for U.S. Appl. No. 11/441,668., 15 pages. |
Sakura Finetek, Japanese Office Action mailed Jan. 30, 2012 for Application No. 2009-512152, 6 pages. |
Sakura Finetek USA, Inc., Canadian Office Action dated Feb. 25, 2013 for Appln. No. 2652898. |
Sakura Finetek USA, Inc., Final Office Action dated Mar. 14, 2013 for U.S. Appl. No. 13/018,609. |
Sakura Finetek, Extended Search Report mailed Jun. 4, 2012 for EP Appln. No. 12153210.5, 6 pages. |
Sakura Finetek, Japanese Office Action dated Jul. 19, 2012 for Appln. No. 2009-512152 with English translation, 4 pages. |
Sakura Finetek, Office Action mailed Jun. 25, 2012; EP Appln No. 07795292.7, 6 pp. |
Sakura Finetek, CN Notification of Reexamination dated Sep. 18, 2012 for Chinese Appln. No. 200610007366.7. |
Sakura Finetek, Australian Office Action mailed Sep. 21, 2012 for Application No. 2007267881. |
Sakura Finetek, Non-Final Office Action dated Oct. 23, 2012 for U.S. Appl. No. 13/018,609. |
Sakura Finetek U.S.A., Inc., “Australian Examination Report”, AU Application No. 2012202090, (Mar. 28, 2014). |
Sakura Finetek U.S.A., Inc., “Brazilian Office Action”, BR Application No. PI0602274-0, (Feb. 2, 2016). |
Sakura Finetek U.S.A., Inc., “Chinese Office Action”, CN Application No. 2012103596084, with English translation (Jan. 12, 2016), 12 pages. |
Sakura Finetek U.S.A., Inc., “European office action”, EP Application No. 12153210.5, (Jan. 7, 2015), 4 pages. |
Sakura Finetek U.S.A., Inc., “European Office Action”, EP Appln. No. 04780745.8, (Oct. 20, 2015), 6 pages. |
Sakura Finetek U.S.A., Inc., “Final office action”, U.S. Appl. No. 13/238,511, (Apr. 5, 2013). |
Sakura Finetek U.S.A., Inc., “Final office action”, U.S. Appl. No. 13/018,609, (Oct. 9, 2013). |
Sakura Finetek U.S.A., Inc., “Final office action”, U.S. Appl. No. 14/579,858, (Apr. 12, 2016). |
Sakura Finetek U.S.A., Inc., “Japanese Office Action”, JP Application No. 2009-512152, (Jul. 19, 2012). |
Sakura Finetek U.S.A., Inc., “Japanese Office Action”, JP Appln. No. 2012-012269, with English translation, (Jul. 7, 2015), 31 pages. |
Sakura Finetek U.S.A., Inc., “Non-final office action”, U.S. Appl. No. 14/579,858, (Dec. 22, 2015). |
Sakura Finetek U.S.A., Inc., “Non-final office action”, U.S. Appl. No. 13/238,511, (Jun. 13, 2014). |
Sakura Finetek U.S.A., Inc., “Non-final office action”, U.S. Appl. No. 14/297,537, (Aug. 21, 2014). |
Sakura Finetek U.S.A., Inc., “Non-final office action”, U.S. Appl. No. 13/238,511, (Nov. 29, 2012). |
Sakura Finetek U.S.A., Inc., “Non-final office action”, U.S. Appl. No.13/238,575, (Jan. 25, 2013). |
Sakura Finetek U.S.A., Inc., “Non-final office action”, U.S. Appl. No. 13/018,608, (Jul. 1, 2013). |
Sakura Finetek U.S.A., Inc., “Notice of Allowance”, U.S. Appl. No. 13/018,609, (Feb. 14, 2014). |
Sakura Finetek U.S.A., Inc., “Notice of Allowance”, U.S. Appl. No. 13/238,511, (Nov. 14, 2014). |
Sakura Finetek U.S.A., Inc., “Notice of Allowance”, U.S. Appl. No. 14/297,537, (Dec. 24, 2015). |
Sakura Finetek U.S.A., Inc., “Office Action”, BR Application No. PI0602274-0, (Aug. 18, 2015). |
Sakura Finetek U.S.A., Inc., “Office Action”, AU Application No. 2008229802 (Jul. 21, 2010). |
Sakura Finetek U.S.A., Inc., “Office Action”, AU Application No. 2008229802 (Aug. 13, 2010). |
Sakura Finetek U.S.A., Inc., “Office Action”, EP Application No. 07795292.7-1234 (Oct. 11, 2010). |
European Search Report for EP Appln No. 06101495.7, mailed Dec. 18, 2006 (10 pages). |
European Search Report for EP Appln No. 06101497.3, mailed Jun. 20, 2006 (6 pages). |
Zhang, Guangrong, et al., “Deparaffinization compositions and methods for their use,” U.S. Reissue Appl. No. 11/250,142, filed Oct. 13, 2005. |
Shi, Shan-Rong, et al., “Enhancement of immunochemical staining in aldehyde-fixed tissue,” U.S. Reissue Appl. No. 11/249,180, filed Oct. 11, 2005. |
Sakura Finetek U.S.A., Inc., CN Office Action dated Mar. 31, 2011 for Chinese Appln. No. 200610007366.7, 6 pages. |
Sakura Finetek U.S.A., Inc., Non-final Office Action mailed Feb. 18, 2011 for U.S. Appl. No. 11/441,668, 13 pages. |
Sakura Finetek U.S.A., Inc., Office Action mailed Oct. 11, 2010; European Appln No. 07795292.7-1234, 7 pages. |
Number | Date | Country | |
---|---|---|---|
20060173575 A1 | Aug 2006 | US |
Number | Date | Country | |
---|---|---|---|
60652432 | Feb 2005 | US | |
60678682 | May 2005 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10639021 | Aug 2003 | US |
Child | 11349663 | US |